☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Acorda Therapeutics
Acorda Therapeutics Entered into a Distribution and Supply Agreement with Chance Pharmaceuticals to Commercialize Inbrija in China
May 9, 2023
Acorda Therapeutics Entered into Distribution and Supply Agreements with Biopas to Commercialize Inbrija in Latin America for Park...
May 12, 2022
Grunenthal Acquires Averitas Pharma for its Peripheral Neuropathic Pain Product- Qutenza (capsaicin)
November 15, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.